Christoph U Correll Selected Research

Dementia (Dementias)

1/2023	Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer's dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy.
1/2020	Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches.
1/2020	Mortality risk of antipsychotic augmentation for adult depression.
12/2015	Haloperidol and sudden cardiac death in dementia: autopsy findings in psychiatric inpatients.
6/2014	Body mass index identified as an independent predictor of psychiatric readmission.
5/2014	National trends in second-generation antipsychotic augmentation for nonpsychotic depression.
10/2012	Risk factors for medical deterioration of psychiatric inpatients: opportunities for early recognition and prevention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph U Correll Research Topics

Disease

256	Schizophrenia (Dementia Praecox) 05/2024 - 11/2003
78	Psychotic Disorders (Schizoaffective Disorder) 05/2024 - 04/2007
74	Weight Gain 11/2023 - 08/2004
44	Bipolar Disorder (Manic Depressive Psychosis) 01/2024 - 01/2007
37	Mental Disorders (Mental Disorder) 04/2024 - 06/2005
27	Treatment-Resistant Schizophrenia 04/2024 - 08/2011
23	Body Weight (Weight, Body) 01/2023 - 01/2011
22	Tardive Dyskinesia 05/2024 - 03/2004
21	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 06/2005
20	Obesity 11/2023 - 08/2004
17	Insulin Resistance 01/2023 - 01/2007
16	Anorexia Nervosa 12/2023 - 06/2012
15	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2024 - 10/2009
15	Substance-Related Disorders (Drug Abuse) 03/2024 - 01/2009
15	Psychomotor Agitation (Akathisia) 11/2023 - 07/2010
13	Type 2 Diabetes Mellitus (MODY) 01/2023 - 08/2010
12	Dyskinesias (Dyskinesia) 05/2024 - 03/2004
11	Hyperprolactinemia 01/2023 - 01/2004
11	Hypertension (High Blood Pressure) 01/2023 - 11/2008
11	Dyslipidemias (Dyslipidemia) 01/2023 - 11/2008
11	Mania (Manias) 01/2022 - 03/2010
9	Major Depressive Disorder (Major Depressive Disorders) 11/2023 - 08/2011
9	Sleepiness 01/2023 - 04/2012
9	Mood Disorders (Mood Disorder) 01/2023 - 03/2013
9	Weight Loss (Weight Reduction) 01/2021 - 06/2007
8	Neurobehavioral Manifestations 01/2023 - 01/2011
8	Parkinsonian Disorders (Parkinsonism) 12/2022 - 09/2015
7	Dementia (Dementias) 01/2023 - 10/2012
7	Agranulocytosis (Granulocytopenia) 03/2022 - 02/2012
7	Neuroleptic Malignant Syndrome 10/2021 - 02/2012
7	Overweight 02/2020 - 09/2010
6	Neoplasms (Cancer) 04/2024 - 11/2015
6	Myocarditis (Carditis) 11/2023 - 02/2012
6	Coronary Disease (Coronary Heart Disease) 01/2023 - 04/2006
6	Depressive Disorder (Melancholia) 10/2022 - 04/2015
6	COVID-19 10/2022 - 01/2020
6	Cognitive Dysfunction 03/2021 - 07/2012
6	Prediabetic State (Prediabetes) 11/2020 - 04/2012
6	Autism Spectrum Disorder 12/2019 - 10/2013
5	Inflammation (Inflammations) 03/2024 - 01/2020
5	Hyperglycemia 01/2023 - 11/2008
5	Autistic Disorder (Autism) 01/2022 - 10/2009
5	Alcoholism (Alcohol Abuse) 01/2021 - 11/2010
5	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2020 - 10/2011
5	Diabetes Mellitus 06/2015 - 05/2009
4	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2020
4	Drug-Related Side Effects and Adverse Reactions 12/2023 - 01/2020
4	Intellectual Disability (Idiocy) 11/2023 - 01/2016
4	Pain (Aches) 01/2023 - 01/2017
4	Nausea 01/2023 - 05/2016

Drug/Important Bio-Agent (IBA)

298	Antipsychotic Agents (Antipsychotics)IBA 05/2024 - 11/2003
68	Clozapine (Clozaril)FDA LinkGeneric 04/2024 - 01/2007
47	Olanzapine (Zyprexa)FDA Link 05/2024 - 03/2008
43	Aripiprazole (Abilify)FDA Link 11/2023 - 01/2007
31	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2024 - 01/2004
30	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2005
29	Quetiapine Fumarate (Seroquel)FDA Link 05/2024 - 01/2007
26	ProlactinIBA 04/2024 - 01/2004
23	Antidepressive Agents (Antidepressants)IBA 12/2023 - 04/2007
20	LipidsIBA 01/2023 - 01/2007
15	Insulin (Novolin)FDA Link 01/2023 - 10/2010
12	Polytetrafluoroethylene (Teflon)FDA Link 03/2024 - 01/2016
12	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2007
11	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 01/2016
11	HDL CholesterolIBA 09/2017 - 04/2006
10	ziprasidone (Geodon)FDA Link 05/2024 - 01/2007
10	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2010
10	CholesterolIBA 01/2023 - 04/2006
10	Lurasidone Hydrochloride FDA Link 01/2023 - 09/2012
9	Paliperidone Palmitate FDA Link 02/2024 - 09/2012
9	Cholinergic Antagonists (Anticholinergics)IBA 12/2022 - 07/2010
9	BenzodiazepinesIBA 12/2022 - 07/2010
9	Metformin (Glucophage)FDA LinkGeneric 11/2020 - 06/2010
8	valbenazineIBA 05/2024 - 01/2016
8	Serotonin (5 Hydroxytryptamine)IBA 01/2023 - 01/2012
7	Dopamine Receptors (Dopamine Receptor)IBA 12/2023 - 10/2007
7	brexpiprazoleIBA 01/2023 - 09/2015
7	LDL CholesterolIBA 10/2022 - 04/2008
7	TeaIBA 01/2022 - 07/2014
7	Hemoglobins (Hemoglobin)IBA 01/2021 - 10/2012
6	3-carboxamido-4-hydroxynaltrexoneIBA 01/2023 - 01/2018
6	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2023 - 10/2018
5	mesoglycanIBA 02/2024 - 01/2020
5	cariprazineIBA 01/2023 - 01/2019
5	AntioxidantsIBA 10/2022 - 11/2015
5	C-Reactive ProteinIBA 03/2022 - 01/2012
5	LithiumIBA 10/2021 - 10/2016
5	Glutamic Acid (Glutamate)FDA Link 01/2020 - 05/2015
5	HDL LipoproteinsIBA 08/2019 - 04/2006
5	Liraglutide FDA Link 01/2019 - 03/2014
4	Amisulpride (Solian)IBA 09/2023 - 10/2014
4	Narcotic Antagonists (Opioid Antagonists)IBA 08/2023 - 01/2019

Therapy/Procedure

44	Injections 02/2024 - 10/2013
24	Therapeutics 10/2023 - 10/2009
19	Secondary Prevention 02/2024 - 01/2011
17	Polypharmacy 01/2020 - 01/2007
5	Drug Therapy (Chemotherapy) 02/2023 - 11/2010
5	Duration of Therapy 02/2022 - 08/2012
4	Length of Stay 12/2023 - 06/2014
4	Combined Modality Therapy 12/2023 - 03/2015